Atazanavir Sulfate molecular structure

Atazanavir Sulfate

Also known as: Reyataz, Atazor, Virataz (component of Evotaz and boosted second-line regimens)

CAS Number: 229975-97-7

HIV Protease Inhibitor

Pharmacopeia Standards

USPIPEP

Mechanism of Action

Atazanavir is an azapeptide inhibitor that binds selectively within the active site of HIV-1 protease and prevents cleavage of viral gag and gag-pol polyproteins. Blocking this maturation step yields structurally immature, non-infectious virions. It also inhibits UGT1A1-mediated glucuronidation, which accounts for the characteristic reversible unconjugated hyperbilirubinaemia seen with the class member.

Technical Specifications

Generic / INN NameAtazanavir Sulfate
CAS Registry Number229975-97-7
Molecular FormulaC38H54N6O11S
Molecular Weight802.93 g/mol g/mol
Typical PurityNot less than 98.0% on anhydrous basis calculated as atazanavir sulfate
Storage ConditionsStore below 25 degrees C in tightly closed, light-resistant containers protected from moisture.
Shelf Life36 months from date of manufacture in original sealed packing
CategoryAntiretrovirals (HIV)

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Bulk API for 150 mg, 200 mg and 300 mg capsules used in ritonavir-boosted or cobicistat-boosted second-line antiretroviral regimens, and for paediatric oral powder presentations.

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.